Inflammation Research

, Volume 46, Issue 7, pp 243–245 | Cite as

British Inflammation Research Association Meeting: Is there any point in developing an anti-RA drug? National Heart and Lung Institute, London, UK, 21–22 November 1996

  • F. Clay
  • C. Morris


Nitric Oxide Sesquiterpene Lactone Tenidap Human Hsp60 Reduce Bone Loss 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Birkhäuser Verlag, Basel, 1997

Authors and Affiliations

  • F. Clay
    • 1
  • C. Morris
    • 2
  1. 1.R&D Systems Europe, 4-10 The Quadrant, Barton Lane, Abingdon OX14 3YS, UK, Fax +44 1235 533420, e-mail:
  2. 2.Bone and Joint Unit, The Royal London Hospital Medical College, 25–29 Ashfield Street, London E1 2AD, UK, Fax +44 171 377 7735, e-mail:

Personalised recommendations